Resolving the inflammation and restoring LXA4 signaling has been shown to reduce the severity of Alzheimer’s disease such as neuropathology including the decrease in amyloid plaques, tau phospohorylation and inflammation as well as leading to the improvement in the cognitive performance in the 3xTg-AD mouse model [101]. The gene discussed is MAPT; the disease is Alzheimer disease.